tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX

ImmunityBio (IBRX) Revenue

Compare
1,693 Followers

ImmunityBio Revenue

ImmunityBio had a revenue of 32.06M in the quarter ending Sep 30, 2025, with 21.33%. This bring the company's revenue in the last twelve months to 82.56M, Decreased 45.86%. In the fiscal year ending Dec 31, 2024, ImmunityBio had annual revenue of 14.74M with 2270.58% growth.
Revenue (ttm)
82.56M
Revenue Growth
1025.95%
P/S Ratio
138.94
Revenue/Employee
$21,975
Employees
671
Market Cap
$2.05B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
14.74M14.12M+2,370.58%
Dec 31, 2023
622.00K382.00K+259.17%
Dec 31, 2022
240.00K-694.00K+25.70%
Dec 31, 2021
934.00K329.00K+154.38%
Dec 31, 2020
605.00K562.00K+1,407.01%
Dec 31, 2019
43.00K-4.00K+91.49%
Dec 31, 2018
47.00K2.00K+104.45%
Dec 31, 2017
45.00K1.00K+102.28%
Dec 31, 2016
44.00K